Table of contents

• PRP Vaginal Rejuvenation at a Glance
• What Is PRP Vaginal Rejuvenation?
• Who Is a Good Candidate for PRP Vaginal Rejuvenation?
• How Is PRP Vaginal Rejuvenation Performed?
• Why Visit Korea for PRP Vaginal Rejuvenation?
• Key Information for International Patients
• Which Are the Best Clinics in Korea for Prp Vaginal Rejuvenation?
• PRP Vaginal Rejuvenation From Start to Finish
• Alternatives to PRP Vaginal Rejuvenation
• How Can I Prepare for PRP Vaginal Rejuvenation?
• Aftercare Advice

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

Last updated: September 2026

PRP Vaginal Rejuvenation at a Glance

• What it is — PRP vaginal rejuvenation uses platelet-rich plasma made from your own blood and injects it into pre-agreed vaginal, vulvar, clitoral, vestibular, periurethral, or anterior vaginal-wall sites; it is an outpatient injection, not surgical tightening or structural repair.
• Evidence remains limited — A 2026 review found 18 studies with 480 participants but major differences in PRP preparation, injection targets, and outcomes; one small randomized trial found improved overall sexual-function scores after a single anterior vaginal-wall injection, but this does not prove benefit for dryness, pain, laxity, incontinence, or all O-Shot techniques.
• Recovery and activity — Soreness, swelling, bruising, light spotting, or light-headedness can last 1–3 days; avoid intercourse, tampons, cups, sex toys, and douching until tenderness and spotting resolve, and avoid strenuous exercise, cycling, hot baths, and saunas for 24–48 hours.
• Results and repeat sessions — Possible changes should be assessed over weeks to months rather than immediately; the controlled trial checked outcomes at 6 weeks and 6 months, but no proven durability timeline, optimal number of sessions, or maintenance schedule exists.
• Who needs assessment first — A gynecologic or pelvic-health evaluation is important for dryness, painful sex, sexual symptoms, or leakage because PRP does not correct prolapse, childbirth-related muscle injury, urinary retention, or moderate-to-severe incontinence; defer treatment for pregnancy, infection, unexplained bleeding, suspicious lesions, or significant bleeding risk.
• Korea travel planning — For uncomplicated local-anesthetic treatment, plan at least 1–2 days locally after injection; a cautious Korea itinerary is 3–5 calendar days for consultation, examination or testing, treatment, and an optional early review, with no long-haul flight on the same day.
• Korea-specific check — Korea’s advantage is its formal licensed-practice and international-patient framework, not proven superior PRP outcomes; verify the clinician’s Korean license and relevant pelvic-health qualifications, and obtain the exact injection map, PRP system, volumes, anesthetic plan, and English procedure note in writing.

What Is PRP Vaginal Rejuvenation?

PRP vaginal rejuvenation uses platelet-rich plasma prepared from a person’s own blood and injected into selected genital tissues. It is marketed for concerns such as vaginal dryness, discomfort during sex, sexual-function symptoms, or mild urine leakage, although benefits are not established for every use. It is a minimally invasive outpatient injection procedure, not surgical vaginal tightening or structural repair.

Who Is a Good Candidate for PRP Vaginal Rejuvenation?

• Defined, assessed symptoms — Adults with a specific concern such as menopause-related dryness, discomfort with intercourse, sexual-function symptoms, or mild stress-predominant urine leakage can discuss PRP after a gynecologic or pelvic-health assessment.
• Realistic expectations — Suitable candidates understand that PRP is not surgical tightening, does not repair pelvic-organ prolapse or childbirth-related muscle injury, and has no proven universal maintenance schedule.
• Willingness to investigate the cause — Sexual symptoms can arise from pain, medication effects, menopause, pelvic-floor dysfunction, mood, trauma, neurologic disease, or relationship factors. Leakage requires assessment to distinguish stress incontinence from urgency, infection, retention, prolapse, or mixed incontinence.
• Ability to provide informed consent — Candidates should be able to review the intended injection target, PRP preparation method, anesthetic plan, uncertainty of benefit, and plan for follow-up at home.

PRP vaginal rejuvenation is an elective treatment for adults; “vaginal rejuvenation” is a marketing term rather than a diagnosis. Defer treatment during pregnancy or possible pregnancy, and investigate active vaginal, vulvar, pelvic, urinary, or systemic infection; unexplained bleeding; genital ulcers; or a suspicious vulvar, vaginal, or cervical lesion first. Significant anemia, thrombocytopenia, platelet dysfunction, bleeding disorders, and anticoagulant or antiplatelet treatment require individualized assessment; never stop warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, ticagrelor, or aspirin without the prescribing clinician’s direction. Severe pelvic pain, vulvodynia, pelvic-floor hypertonicity, dyspareunia, urinary retention, prolapse, or moderate-to-severe incontinence need condition-specific diagnosis rather than PRP as a substitute.

How Is PRP Vaginal Rejuvenation Performed?

There are no validated patient-facing “types” of PRP vaginal rejuvenation. The clinically important distinction is the injection target and whether it fits the diagnosed problem; preparation systems and protocols are not standardized.

• Vaginal-wall PRP — Intravaginal injections are marketed or studied for dryness, atrophy-related symptoms, discomfort, and painful intercourse. Evidence does not establish PRP as a proven treatment for genitourinary syndrome of menopause (GSM).
• Anterior vaginal-wall or periurethral PRP — This approach has been studied for sexual-function outcomes and is marketed for mild stress urinary incontinence. A 2026 pilot randomized trial evaluated one distal anterior vaginal-wall injection in a narrow premenopausal population; it does not establish PRP as a replacement for established continence care. The trial reported greater overall sexual-function score improvement than saline at 6 weeks, but several individual subscales were not significantly different.
• Clitoral, vestibular, or vulvar PRP — These distinct targets are marketed for arousal, orgasm, sensitivity, vulvar symptoms, or pain. Do not accept an undefined “O-Shot” package without written confirmation of the exact sites and rationale.
• PRP combined with other treatments — Clinics may combine PRP with hyaluronic acid, fat grafting, or other regenerative procedures. Published combination reports cannot show whether benefit or harm came from PRP itself. A review of combination approaches should not be treated as proof for standalone injections.
• Preparation protocol — Blood-draw volume, centrifugation, platelet concentration, leukocyte content, anticoagulant, activator, final PRP volume, needle technique, and session count differ between clinics. The current systematic review found substantial protocol and outcome variation, with no proven best formulation or maintenance interval.

Why Visit Korea for PRP Vaginal Rejuvenation?

There is no high-quality comparative evidence that PRP vaginal rejuvenation in South Korea is safer, more effective, or longer-lasting than comparable care elsewhere. Korea’s relevant advantage for international patients is a formal healthcare and medical-visa framework, not proof of PRP-specific superiority.

• Licensed-practice framework — Korea’s Medical Service Act restricts medical practice to licensed professionals acting within their licensed scope. Ask the institution to provide the clinician’s Korean license details and relevant gynecology, urogynecology, or pelvic-health qualifications.
• International-patient pathway — The Korea Health Industry Development Institute describes medical-visa invitation documentation involving healthcare providers or facilitators registered under the Medical Service Act. Review KHIDI’s guidance when travel requires a medical visa or formal invitation.
• Procedure-specific verification — Request the diagnosis, injection map, PRP system, blood-draw and final PRP volumes, anticoagulant or activator used, local-anesthetic plan, anticipated session plan, and emergency contact route in writing. An “O-Shot” label does not identify a standardized technique.
• Evidence limitation — A Korean academic-hospital report described PRP combined with lipofilling for vaginal atrophy and lichen sclerosus, not standalone vaginal PRP. That case report demonstrates local clinical exploration only, not effectiveness or safety of clinic-marketed PRP injections.

Key Information for International Patients

• Minimum stay — No study establishes a mandatory stay in Korea. For uncomplicated PRP-only treatment with topical or local anesthetic, remain locally for at least 1–2 days after injection; a cautious itinerary allows 3–5 calendar days for consultation, examination, indicated testing, treatment, and an optional early review.
• Appointments and repeat visits — Plan for an in-person assessment even after an English-language video consultation. Do not pre-book repeat PRP as necessary maintenance: no evidence-based session schedule or durability timeline exists.
• Flying — No evidence-based PRP-specific commercial-flight ban exists. Before a long-haul flight, ensure there is no substantial bleeding, fever, faintness, uncontrolled pain, or difficulty urinating; walk regularly and hydrate during travel. Follow individualized thrombosis advice when personal risk factors exist.
• Sedation and transport — Topical or local anesthetic does not usually require an overnight escort. If oral medication, opioids, IV sedation, or deeper sedation is used, do not drive, travel alone, or make major decisions for the clinician-specified interval.
• Recovery impact — Soreness, swelling, bruising, spotting, or light-headedness can occur for 1–3 days. Avoid scheduling a strenuous itinerary, cycling, hot baths, or a long-haul departure immediately after treatment.
• Remote follow-up — Leave with an English procedure note listing injection sites, PRP system, blood and PRP volumes, anesthetics, all additional materials or devices, complications, and prescribed medicines. Arrange access to a gynecologist, urogynecologist, menopause clinician, or pelvic-floor therapist at home.

Travel note: Build flexibility into flights and accommodation. PRP is outpatient care, but urinary difficulty, worsening pain, fever, or heavy bleeding need prompt in-person assessment rather than remote reassurance.

Which Are the Best Clinics in Korea for Prp Vaginal Rejuvenation?

Listed below are some of the best clinics in Korea for prp vaginal rejuvenation.

1. SH Clinic

You may consider SH Clinic if you want vaginal rejuvenation care within a women’s-health setting: its gynecology service offers vaginal fillers, stem-cell injections, vaginal HIFU, vaginal tightening, and implant surgery, with procedures performed directly by an experienced board-certified gynecologist. PRP vaginal rejuvenation is not specifically listed, so you should confirm whether it is offered and whether it suits your concerns.

• URL: SH Clinic Website
• Location: Seocho-gu, Seoul
• Gynecologic care:
  • Procedures are performed directly by a board-certified gynecologist who has received a commendation from the Minister of Health and Welfare.
  • The clinic focuses on women’s health alongside gynecologic and vaginal rejuvenation services.
• Vaginal rejuvenation options:
  • Listed options include vaginal fillers, stem-cell injections, HIFU treatment, vaginal tightening, and implant surgery.
  • Vaginal HIFU is described as a non-surgical ultrasound treatment intended to promote collagen remodeling in the vaginal wall.
• Related services: The clinic also lists cervical and ovarian cancer screening and care for urinary incontinence.

2. Okay Plastic Surgery Clinic

The available information does not list PRP vaginal rejuvenation, gynecologic services, or vaginal rejuvenation treatments at Okay Plastic Surgery Clinic, so you should verify directly whether this procedure is available and who would perform it before considering the clinic for this purpose.

• URL: Okay Plastic Surgery Clinic Website
• Location: Gangnam-gu, Seoul

PRP Vaginal Rejuvenation From Start to Finish

1. Remote screening and English communication — Send a concise history covering the exact symptom, menopause and menstrual history, obstetric history, pelvic procedures, urinary symptoms, cancer history, allergies, medicines, supplements, bleeding history, infection risks, and pregnancy possibility. Confirm whether the clinic offers an English-speaking coordinator, virtual consultation, and written English consent.

2. In-person consultation and diagnosis — The clinician clarifies whether the concern is GSM, pelvic-floor pain, sexual dysfunction, stress leakage, a dermatologic condition, structural change, or another issue. An appropriately consented external and pelvic examination is often needed; urinary symptoms can require urinalysis, urine culture, post-void residual measurement, or further continence assessment.

3. Safety checks and consent — Pregnancy testing, STI testing, urinalysis, CBC/platelet count, or other testing is selected according to symptoms and history. Review that evidence is limited and heterogeneous: a 2026 systematic review identified 18 studies involving 480 participants, with major variation in preparation, target tissue, and outcome measures.

4. Blood draw and PRP processing — A clinician draws venous blood into collection tubes, often with an anticoagulant, then centrifuges it to separate a platelet-containing plasma fraction. Blood volume and processing time vary because no vaginal-PRP protocol has been shown to be best.

5. Numbing and injection — Topical anesthetic, injected local anesthetic, or both can be used. After sterile preparation, the clinician injects PRP into the pre-agreed vaginal, vulvar, clitoral, vestibular, periurethral, or anterior vaginal-wall sites. The blood draw, processing, numbing, injection, and brief observation are generally completed during one outpatient visit; published evidence does not support one universal procedure duration.

6. Observation and discharge — Staff assess bleeding, faintness, allergy symptoms, escalating pain, and ability to urinate before discharge. Obtain written aftercare, direct urgent-contact details, and the complete procedure record before leaving.

7. Assessment after returning home — Possible symptom changes should be assessed over weeks to months, not immediately after injection. The controlled trial assessed outcomes at 6 weeks and 6 months after one injection, but this is an assessment schedule rather than a proven result timeline or repeat-treatment rule. Its findings apply only to the study’s defined premenopausal population and anterior-wall technique.

Alternatives to PRP Vaginal Rejuvenation

The right alternative depends on the diagnosis. Non-surgical options often address hormonal, urinary, pain, or pelvic-floor causes directly; surgery is reserved for documented anatomical problems and carries more substantial recovery and complication considerations.

GSM and Vaginal Dryness

• Hormonal and non-hormonal care — Lubricants and vaginal moisturizers can help mild symptoms. For moderate-to-severe GSM, evidence-supported options include low-dose vaginal estrogen, vaginal DHEA/prasterone, systemic hormone therapy when otherwise indicated, and oral ospemifene. The GSM position statement supports diagnosis-specific care; those with hormone-sensitive cancer need individualized oncology and menopause-care input.
• Related procedure guide — Read about vaginal dryness treatment for diagnosis-led options.

Pelvic-Floor Pain and Dyspareunia

• Cause-directed treatment — Pelvic-floor physical therapy, treatment of vulvar dermatoses or infection, vaginal dilator therapy when appropriate, lubrication, and sexual counseling can address pain mechanisms that PRP does not correct.
• Assessment priority — Persistent pain, burning, skin changes, and pain with penetration require a pelvic-health or gynecology assessment before an elective injection.

Stress Urinary Incontinence

• Established continence options — Pelvic-floor muscle training, biofeedback, continence pessaries or inserts, urethral bulking, and surgery such as a midurethral sling or colposuspension are established treatments selected by leakage type and severity. ACOG’s patient guidance explains the diagnostic distinction and treatment range.
• Related procedure guide — See female incontinence treatment for condition-specific approaches.

Structural Laxity or Prolapse

• Surgical repair when indicated — Prolapse, perineal injury, obstetric muscle injury, and documented structural laxity need gynecology or urogynecology assessment. Perineoplasty, pelvic-floor repair, or vaginoplasty may be considered for an anatomical indication; PRP is not an equivalent repair.
• Related procedure guides — Compare pelvic muscle restoration surgery and vaginoplasty.

Energy-Based Vaginal Procedures

• Laser or radiofrequency caution — These procedures are marketed for similar goals but are not automatically evidence-based alternatives. ACOG notes the FDA warning that energy-based devices have not been cleared or approved in the United States for vaginal “rejuvenation,” menopausal symptoms, urinary incontinence, or sexual function, and identifies burns, scarring, dyspareunia, and chronic pain as risks.
• Related procedure guide — Review laser vaginal rejuvenation with the same diagnostic caution.

How Can I Prepare for PRP Vaginal Rejuvenation?

• Disclose every medicine and supplement — Provide prescription, over-the-counter, hormonal, injectable, and supplement lists well before travel. Specifically identify anticoagulants, antiplatelets, NSAIDs, corticosteroids, fish oil/omega-3, vitamin E, ginkgo, garlic, and turmeric/curcumin because they can affect bleeding or platelet activity.
• Do not stop essential drugs independently — The prescribing clinician and treating clinician must decide whether warfarin, aspirin, clopidogrel, apixaban, rivaroxaban, dabigatran, hormone treatment, or other medicines can be altered safely. There is no evidence-based universal stop period for NSAIDs or supplements in vaginal PRP.
• Complete indicated testing — Expect targeted urine, pregnancy, STI, CBC/platelet, or abnormal-bleeding testing when symptoms or medical history justify it. Report discharge, itching, fever, pelvic pain, irregular bleeding, urinary burning, anemia, or a recent infection before traveling.
• Eat and hydrate unless sedation changes the plan — Topical or local anesthetic generally does not require fasting. Follow fasting instructions exactly if sedation is planned.
• Avoid alcohol and recreational drugs — Avoid them before the appointment, particularly when anesthetic, anxiolytic medication, or sedation is planned. No vaginal-PRP study defines a nicotine-free interval, although avoiding nicotine supports general vascular health.
• Prepare for light spotting — Bring loose, breathable underwear and sanitary pads. Avoid tampons on the treatment day unless the clinic specifically instructs otherwise.
• Plan transport and accommodation — Stay near the facility for the first night when possible, with easy bathroom access. Arrange a companion and private transport if sedation, opioid pain medicine, or significant anxiety is expected.
• Keep flights flexible — Do not book a long-haul departure for the same day. Allow time for an in-person assessment if bleeding, faintness, urinary symptoms, or escalating pain occurs.

Travel note: Send translated or original records of relevant Pap/HPV testing, pelvic procedures, continence evaluation, cancer treatment, and current medicines before the virtual consultation when available.

Confirm the clinic’s testing, fasting, medication, transport, and travel requirements directly; the treating doctor’s individualized instructions take precedence over general guidance.

Aftercare Advice

Protect the treated area from friction and monitor symptoms closely during the first several days; PRP aftercare is simple, but infection, urinary difficulty, and worsening pain need prompt evaluation.

• Spotting and comfort — Use a sanitary pad for light spotting, wear loose underwear, and keep the external genital area clean. Use acetaminophen/paracetamol only if medically safe and clinician-approved; do not automatically take NSAIDs after PRP because clinic protocols differ and no evidence-based vaginal-PRP interval exists.
• Vaginal insertion — Avoid intercourse, tampons, menstrual cups, douching, and sex toys until tenderness and spotting resolve and the treating clinician clears activity. One small study instructed 2–3 days of abstinence, but this is not a universal rule; extensive or painful injections can require a longer restriction.
• Exercise, heat, and friction — Avoid strenuous exercise, cycling, horseback riding, hot tubs, and saunas for 24–48 hours when they increase pelvic pressure, heat, friction, discomfort, or spotting. Gentle walking is reasonable when feeling well.
• Warning signs — Seek urgent local medical evaluation for heavy or persistent bleeding, fever or chills, foul-smelling discharge, worsening pelvic or vulvar pain, spreading redness or swelling, rash or breathing difficulty, inability to urinate, painful urination with systemic symptoms, chest pain, shortness of breath, or new leg swelling.
• Follow-up and results — Contact the clinic through the agreed pathway after returning home and share the procedure note with a local clinician when symptoms persist. There is no reliable universal final-result date; the 2026 randomized trial measured outcomes at 6 weeks and 6 months, not immediately after treatment. Reassess the original concern before considering another session.

Follow the treating doctor’s instructions when they differ from this guidance, and contact the clinic promptly when anything appears wrong.